| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nsclc cancer stage 4 | 0.3 | 0.7 | 616 | 90 | 20 |
| nsclc | 0.61 | 0.1 | 9133 | 17 | 5 |
| cancer | 0.26 | 0.7 | 7848 | 38 | 6 |
| stage | 1.77 | 0.8 | 7382 | 24 | 5 |
| 4 | 1.39 | 1 | 1783 | 14 | 1 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nsclc cancer stage 4 | 0.17 | 0.6 | 5436 | 88 |
| nsclc stage 4 lung cancer egfr exon 20 | 1.24 | 0.4 | 7522 | 16 |
| stage 4 nsclc lung cancer | 1.25 | 0.8 | 5468 | 78 |
| what is stage 4 nsclc | 1.11 | 0.8 | 8834 | 83 |
| stage 4 nsclc survivors | 0.66 | 0.5 | 9189 | 47 |
| nsclc stage 4 clinical trials | 1.75 | 0.6 | 749 | 81 |
| nsclc stage 4 treatment | 1.18 | 0.2 | 6700 | 41 |
| stage 4 nsclc prognosis | 0.49 | 0.3 | 8757 | 85 |
| stage 4 scl cancer | 1.19 | 0.3 | 8522 | 43 |
| nsclc adenocarcinoma stage 4 | 1.23 | 0.5 | 8687 | 18 |
| stage 4 nsclc therapy option | 0.4 | 0.3 | 7429 | 74 |
| stage 4 nsclc survival rate | 1.86 | 0.5 | 4869 | 83 |
| metastatic stage 4 nsclc prognosis | 0.95 | 0.6 | 1322 | 41 |
| immunotherapy for nsclc stage 4 | 1.04 | 0.1 | 7893 | 7 |
| stage 4 nsclc remission | 1.85 | 1 | 1938 | 75 |
| stage 4 nsclc life expectancy | 1.47 | 0.9 | 6071 | 89 |
| is stage 4 nsclc curable | 1.43 | 0.3 | 1448 | 59 |
| nsclc stage 4b prognosis | 0.03 | 0.2 | 1855 | 76 |
| stage iv nsclc prognosis | 0.52 | 0.2 | 7213 | 67 |
